ATAI Life Sciences AG 4
4 · COMPASS Pathways plc · Filed Sep 27, 2024
Insider Transaction Report
Form 4
ATAI Life Sciences B.V.
10% Owner
Transactions
- Sale
Ordinary Shares
2024-09-26$6.05/sh−2,660,000$16,093,000→ 6,905,774 total(indirect: By ATAI Life Sciences AG)
Footnotes (1)
- [F1]Securities held of record by ATAI Life Sciences AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the Ordinary Shares held of record by ATAI Life Sciences AG.